Indivior Pharmaceuticals (INDV) Return on Invested Capital (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Return on Invested Capital of 0.04% for Q1 2026, up 5.0% year-over-year from 0.04% in Q1 2025, and up 28.9% quarter-over-quarter from 0.03% in Q4 2025.
Indivior Pharmaceuticals (INDV) Return on Invested Capital (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.04% for Q1 2026.
- In Q1 2026, Return on Invested Capital rose 5.0% year-over-year to 0.04%; the TTM figure through Mar 2026 stood at 0.04% (up 5.0% YoY), while the FY2025 annual figure was 0.1%, up 10.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.04%, up from 0.03% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.04% in Q1 2026, with the low at 0.01% in Q1 2025.
- The 3-year median for Return on Invested Capital is 0.03% (2025), against an average of 0.02%.
- The sharpest annual moves came in 2025 and 2026: Return on Invested Capital grew 3 bps in 2025, then climbed 5 bps in 2026.
- Indivior Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2024, then jumped by 3574 bps to 0.03% in 2025, then grew by 29 bps to 0.04% in 2026.
- Business Quant data shows INDV's Return on Invested Capital at 0.04% in Q1 2026, 0.03% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.57 Bn | 4.35 Bn | 294.00 Mn | 0.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.07% |
| Mar 31, 2026 | 0.04% |
| Dec 31, 2025 | 0.03% |
| Sep 30, 2025 | 0.02% |
| Jun 30, 2025 | 0.03% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | 0.00% |